← Back to Clinical Trials
Recruiting NCT05814510

NCT05814510 Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05814510
Status Recruiting
Phase
Sponsor Johns Hopkins University
Condition Asthma in Children
Study Type INTERVENTIONAL
Enrollment 1,000 participants
Start Date 2023-11-27
Primary Completion 2027-06-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Asthma CHAMPS full programAsthma CHAMPS Wait List Control

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,000 participants in total. It began in 2023-11-27 with a primary completion date of 2027-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The long-term goal is to implement an evidence-based asthma intervention based on the Center for Disease Control's recommended framework (EXHALE) within Baltimore City Public Schools (BCPS). As part of a stepped wedge pragmatic trial the investigators will: 1. Evaluate the effectiveness of a tailored implementation plan of Asthma CHAMPS in 32 Baltimore city elementary schools to reduce asthma disparities. 2. Conduct a pragmatic trail using a stepped wedge design to evaluate implementation of a school and home asthma intervention program to reduce asthma-related absences, healthcare utilization and exacerbations and improve asthma control, among children enrolled in 32 Baltimore City elementary schools. 3. Use qualitative methods (observation and semi structured interviews) to obtain stakeholder feedback (parents, community health workers, school personnel and administrators) on impact of Asthma CHAMPS, identify potential refinements in intervention and implementation strategies, and evaluate impact of local adaptation and fidelity on implementation success and sustainability.

Eligibility Criteria

Adult Inclusion Criteria: * Aged 18 or older * Current caregiver of child with asthma or staff member at a Baltimore City K-8 Public School in Asthma CHAMPS Exclusion Criteria: * Unwilling to consent Children with asthma Inclusion Criteria: * Asthma diagnosis * Currently enrolled in Baltimore City K-8 Public School participating in Asthma CHAMPS Exclusion Criteria: * Unwilling to provide assent

Contact & Investigator

Central Contact

Michelle N Eakin, PhD

✉ meakin1@jhmi.edu

📞 410-550-0487

Principal Investigator

Michelle N Ealin, PhD

PRINCIPAL INVESTIGATOR

JHU

Frequently Asked Questions

Who can join the NCT05814510 clinical trial?

This trial is open to participants of all sexes, studying Asthma in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05814510 currently recruiting?

Yes, NCT05814510 is actively recruiting participants. Contact the research team at meakin1@jhmi.edu for enrollment information.

Where is the NCT05814510 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT05814510 clinical trial?

NCT05814510 is sponsored by Johns Hopkins University. The principal investigator is Michelle N Ealin, PhD at JHU. The trial plans to enroll 1,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology